Publicado em 27 abr 2022
The Lancet: Lung cancer – When less is more in thoracic surgery
LCSG821 has since been criticised because it was performed when the diagnosis of lung cancer was based on simple chest x-rays performed for symptoms. Access to CT scans was also limited, and no patients received a PET scan. Further, LCSG821 did not provide pulmonary function data, and recurrences were defined from x-rays. Finally, the trial was underpowered for adequate survival analysis and the overall survival difference was interpreted as being superior but today would not have been considered significant (p=0·088).
Leia artigo completo em https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02720-3/fulltext?dgcid=raven_jbs_etoc_email
